Does smoking cessation reduce coronary death and non-fatal coronary events in patients with coronary heart disease?
Smoking cessation is emphasized in all recommendations for secondary prevention of coronary heart disease to reduce coronary death and non-fatal events.
Although it is well known that smoking is strongly associated with coronary heart disease, many continue or resume smoking after being diag- with coronary heart disease and even after an event such as a myocardial infarction, angio- or coronary bypass surgery. The evidence that causes cardiovascular disease and new events patients with coronary heart disease, among other disorders such as lung cancer and emphysema, fies the promotion of smoking cessation. All rec- on the prevention of coronary heart dis- emphasize the importance of smoking cessation in reduction of the risk of coronary death and non-fatal events3, 4. The recent EUROASPIRE study on status of secondary prevention of coronary heart in nine European countries has shown, however, success in smoking cessation among coronary
T. Van Berkel (Wed,) studied this question.